Name:
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
Type:
Synthetic cannabinoid
AKA:
THJ-2201
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone image
Synthetic substance, no natural derivative
IUPAC Logo
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone image
THJ-2201, a synthetic cannabinoid, was first identified in the early 2010s. It was developed to interact with cannabinoid receptors and mimic THC's effects. The compound found its way into synthetic cannabis products, gaining popularity in the recreational market. THJ-2201's potent psychoactive effects and health risks have led to increased regulation and efforts to control synthetic cannabinoids.
Synthetic Substances Image
THJ-2201 is a synthetic cannabinoid with potent psychoactive effects. It acts as an upper, producing euphoria and altered perceptions. Short-term use can result in intense psychoactive effects, while long-term effects are less understood. Overdose risks include severe psychological effects and potential toxicity. Safe use is uncertain due to limited research. Recent studies focus on its potency and potential health risks.
N/A
THJ-2201, a synthetic cannabinoid, affects cannabinoid receptors, leading to euphoria and altered perception. Immediate effects include mood elevation and sensory distortions, lasting several hours. Long-term use may result in severe psychological effects such as paranoia and cognitive impairments. Research underscores its potent effects and risks of dependence and mental health issues.
N/A
N/A
N/A